home / stock / mmed:cc / mmed:cc quote
Last: | $1.07 |
---|---|
Change Percent: | -4.46% |
Open: | $1.11 |
Close: | $1.07 |
High: | $1.11 |
Low: | $1.04 |
Volume: | 224,180 |
Last Trade Date Time: | 05/06/2022 04:52:07 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.07 | $1.11 | $1.07 | $1.11 | $1.04 | 224,180 | 05-06-2022 |
$1.12 | $1.18 | $1.12 | $1.18 | $1.06 | 589,682 | 05-05-2022 |
$1.16 | $1.12 | $1.16 | $1.53 | $1.1 | 462,452 | 05-04-2022 |
$1.1 | $1.09 | $1.1 | $1.13 | $1.07 | 284,933 | 05-03-2022 |
$1.08 | $1.02 | $1.08 | $1.08 | $1.02 | 281,530 | 05-02-2022 |
$1.04 | $1.08 | $1.04 | $1.11 | $1.02 | 215,833 | 04-29-2022 |
$1.08 | $1.07 | $1.08 | $1.09 | $1.01 | 290,617 | 04-28-2022 |
$1.03 | $1.12 | $1.03 | $1.12 | $1 | 505,158 | 04-27-2022 |
$1.04 | $1.12 | $1.04 | $1.12 | $1.01 | 357,925 | 04-26-2022 |
$1.1 | $1.08 | $1.1 | $1.12 | $1.07 | 243,326 | 04-25-2022 |
$1.12 | $1.09 | $1.12 | $1.13 | $1.05 | 423,909 | 04-22-2022 |
$1.08 | $1.1 | $1.08 | $1.14 | $1.04 | 691,369 | 04-21-2022 |
$1.14 | $1.15 | $1.14 | $1.15 | $1.09 | 479,763 | 04-20-2022 |
$1.15 | $1.21 | $1.15 | $1.21 | $1.13 | 418,147 | 04-19-2022 |
$1.16 | $1.21 | $1.16 | $1.24 | $1.15 | 690,227 | 04-18-2022 |
$1.22 | $1.3 | $1.22 | $1.3 | $1.21 | 580,246 | 04-15-2022 |
$1.22 | $1.3 | $1.22 | $1.3 | $1.21 | 580,246 | 04-14-2022 |
$1.28 | $1.24 | $1.28 | $1.29 | $1.21 | 204,530 | 04-13-2022 |
$1.23 | $1.21 | $1.23 | $1.27 | $1.2 | 420,994 | 04-12-2022 |
$1.21 | $1.21 | $1.21 | $1.25 | $1.18 | 815,936 | 04-11-2022 |
News, Short Squeeze, Breakout and More Instantly...
MIND MEDICINE INC. Company Name:
MMED:CC Stock Symbol:
AQNC Market:
Hallucinogenic persistent perception disorder (HPPD) is an intoxication disorder caused by psychedelic drugs that encompasses a range of visual disturbances that occur in different time frames. The disorder also causes extreme anxiety as well as out-of-body sensations and is marked by shame as w...
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (Cboe Canada: MMED), (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced today that it will present posters describing the...
All Common shares will remain listed on Nasdaq Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (Cboe Canada: MMED) (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today ...